A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic dermatitis and psoriasis molecular markers. Image: Adobe Stock.

Along with your symptoms, the most telling signs are the skin and nail changes you get with psoriasis, or specific changes in your X-rays. You may get referred to a rheumatologist-- doctors who ...

Currently available biomarkers are more useful to rule out than to rule in a diagnosis of infection. Panels of biomarkers may be of more use than any individual marker for diagnosis of sepsis ...

The identification of 16 additional genetic markers will help researchers ... some consumers might assume they have psoriasis without getting a formal diagnosis. "There was some misclassification ...

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

including lipids, metabolites, and peptides; clinical markers ... to assist with PsA diagnosis (iPROLEPSIS), to distinguish subtypes of atopic dermatitis and psoriasis using biomarkers (BIOMAP ...

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers ...

The researchers' findings may form the basis for developing new treatment, diagnostic and prevention strategies. Around 250,000 people in Austria suffer from psoriasis. One third of them develop ...

and cardiovascular risk markers. Eligible participants were 18 years or older and had a diagnosis of moderate to severe plaque psoriasis. A total of 20 patients were included; 55% were male ...

Here, the authors will review our changing approaches to sepsis diagnosis and discuss some of the markers that seem most relevant at the present time. The traditional approach to sepsis diagnosis ...